Trial corona vaccination for infants scheduled in July!
Posted on: 18/Jun/2021 11:49:48 AM
Serum Institute, located at Pune (Maharashtra), has the licence to manufacture the vaccine developed by the USA’s NovaVax.
As such, the latest information is that it is established through trial runs that the vaccine developed by NovaVax is effective at 90% extent.
Subsequently, NovaVax has applied to the USA Medicine Regulation Agency for permission to use it on an emergency basis.
In this situation, Serum Institute has planned to introduce NovaVax in India in September.
Serum Institute has further informed that it has planned to conduct a trial run by administering the new vaccine to infants in July.
